Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
07-09 April, 2026
Health 2.0 ConferenceHealth 2.0 Conference
Not Confirmed
Not Confirmed
07-09 April, 2026
Not Confirmed
Not Confirmed
09-12 April, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS




Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
07-09 April, 2026
Health 2.0 ConferenceHealth 2.0 Conference
Industry Trade Show
Not Confirmed
07-09 April, 2026
Industry Trade Show
Not Confirmed
09-12 April, 2026
Digital content

27 Mar 2026
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/castle-biosciences-decisiondx-melanoma-test-significantly-improves-risk-prediction-within-ajcc-stages-to-support-personalized-risk-aligned-management-of-cutaneous-melanoma-data-to-be-presented-at-aad-2026-302725368.html

13 Mar 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/03/13/3255641/0/en/Prospective-Multi-center-Study-Published-in-Future-Oncology-Demonstrates-DecisionDx-Melanoma-s-i31-SLNB-Result-Outperforms-Staging-Criteria-in-Identifying-Patients-with-Cutaneous-M.html

09 Mar 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/03/09/3251673/0/en/DecisionDx-Melanoma-s-i31-SLNB-Report-from-the-Largest-Prospective-Multicenter-Study-to-Date-Confirms-2-6-Nodal-Positivity-in-Patients-Predicted-to-Have-Less-Than-5-Risk.html

04 Mar 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/03/04/3249752/0/en/Castle-Biosciences-to-Present-Data-at-SSO-2026-on-DecisionDx-Melanoma-s-i31-SLNB-Identifying-T1b-T2a-Melanoma-Patients-Who-May-Safely-Avoid-SLNB.html

03 Mar 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/03/03/3248963/0/en/Castle-Biosciences-Announces-Grand-Opening-of-New-Corporate-Headquarters-in-Friendswood-Texas.html

19 Feb 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/02/19/3241623/0/en/Prospective-Validation-Study-in-JAAD-Demonstrates-Castle-Biosciences-AdvanceAD-Tx-Test-Identifies-Patients-More-Likely-to-Achieve-Faster-and-Deeper-Responses-with-JAK-Inhibitor-The.html
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE